Browsing Tag
General Atlantic
20 posts
Belle Brands acquires Vegamour as Windsong Global expands beauty portfolio
Belle Brands has acquired hair-wellness company Vegamour for undisclosed terms, adding another digitally born beauty business to a portfolio that now spans hair care, skincare, cosmetics and baby personal care.
ByteDance’s $29.6bn loan is not a rescue financing, it is what an AI arms race looks like on a profitable balance sheet
ByteDance has reportedly expanded a planned $20 billion syndicated loan to $29.6 billion after lender demand exceeded $30 billion. The TikTok owner is considering as much as $70 billion of 2026 capital spending, largely around AI infrastructure, yet the loan is priced more cheaply than its previous offshore facility. For one of the world’s most valuable private companies, the financing shows how profitable AI leaders are beginning to combine enormous internal cash generation with public-company-scale debt markets.
Shein finally got its IPO, but the valuation tells a very different story from the one private investors bought
Shein is set to enter Hong Kong’s public market at about $26.5 billion, far below its 2022 private-market peak. The discounted valuation may improve the entry point for new shareholders, but slower growth, weaker margins and up to $3.5 billion of payments linked to earlier preferred shares expose how expensive the company’s long-delayed IPO has become.
Why Seaport’s U.S. IPO filing matters now for neuropsychiatric drug development and biotech capital markets
Seaport Therapeutics has filed for a U.S. IPO. Read how its neuropsychiatry pipeline could test biotech investor appetite in 2026.
Lilly bets $7.8bn on orexin science with Centessa acquisition as neuroscience race intensifies
Eli Lilly agrees to acquire Centessa Pharmaceuticals for $6.3B, gaining orexin sleep drug cleminorexton. Read the full strategic analysis.
Rubicon Research IPO: Can General Atlantic’s Rs 1,377cr exit test pharma market appetite?
Rubicon Research’s ₹1,377 crore IPO opens Oct 9. Backed by General Atlantic, can this pharma play sustain growth and deliver listing gains?
Rubicon Research Rs 140cr pre-IPO boost: Can the pharma firm deliver sustained growth?
Rubicon Research secures ₹140 crore from TIMF Holdings and 360 ONE Funds ahead of IPO. Find out how the pharma player is positioning for growth.
QI Tech becomes unicorn with extended Series B funding from General Atlantic and Across Capital
QI Tech, a titan in the financial services infrastructure sector in Brazil, has just scaled new heights, achieving…
HireRight to be acquired for $1.6bn by General Atlantic and Stone Point Capital
HireRight Holdings Corporation (NYSE: HRT), a preeminent provider of global background screening services and workforce solutions, has announced…
General Atlantic to acquire Actis in strategic $96bn AUM merger
General Atlantic, a leading global growth investor, and Actis, a key player in sustainable infrastructure investment, have announced…